126 related articles for article (PubMed ID: 26416710)
1. Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Ann Surg Oncol; 2016 Feb; 23(2):403-9. PubMed ID: 26416710
[TBL] [Abstract][Full Text] [Related]
2. Margin Positivity and Survival Outcomes: A Review of 14,471 Patients with 1-cm to 4-cm Papillary Thyroid Carcinoma.
Khan ZF; Kutlu O; Picado O; Lew JI
J Am Coll Surg; 2021 Apr; 232(4):545-550. PubMed ID: 33421566
[TBL] [Abstract][Full Text] [Related]
3. Should an involved but functioning recurrent laryngeal nerve be shaved or resected in a locally advanced papillary thyroid carcinoma?
Lang BH; Lo CY; Wong KP; Wan KY
Ann Surg Oncol; 2013 Sep; 20(9):2951-7. PubMed ID: 23636513
[TBL] [Abstract][Full Text] [Related]
4. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
5. Lymphovascular invasion is associated with survival for papillary thyroid cancer.
Pontius LN; Youngwirth LM; Thomas SM; Scheri RP; Roman SA; Sosa JA
Endocr Relat Cancer; 2016 Jul; 23(7):555-62. PubMed ID: 27317633
[TBL] [Abstract][Full Text] [Related]
6. Extrathyroidal Extension Is Associated with Compromised Survival in Patients with Thyroid Cancer.
Youngwirth LM; Adam MA; Scheri RP; Roman SA; Sosa JA
Thyroid; 2017 May; 27(5):626-631. PubMed ID: 27597378
[TBL] [Abstract][Full Text] [Related]
7. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
8. Margin Positivity and Survival in Papillary Thyroid Microcarcinoma: A National Cancer Database Analysis.
Lee CI; Kutlu O; Khan ZF; Picado O; Lew JI
J Am Coll Surg; 2021 Oct; 233(4):537-544. PubMed ID: 34265429
[TBL] [Abstract][Full Text] [Related]
9. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients.
Adam MA; Pura J; Gu L; Dinan MA; Tyler DS; Reed SD; Scheri R; Roman SA; Sosa JA
Ann Surg; 2014 Oct; 260(4):601-5; discussion 605-7. PubMed ID: 25203876
[TBL] [Abstract][Full Text] [Related]
10. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: a retrospective analysis of 700 patients.
Loh KC; Greenspan FS; Gee L; Miller TR; Yeo PP
J Clin Endocrinol Metab; 1997 Nov; 82(11):3553-62. PubMed ID: 9360506
[TBL] [Abstract][Full Text] [Related]
11. Impact of extensive neck dissection on survival from papillary thyroid cancer.
Kandil E; Friedlander P; Noureldine S; Islam T; Tufano RP
ORL J Otorhinolaryngol Relat Spec; 2011; 73(6):330-5. PubMed ID: 21997375
[TBL] [Abstract][Full Text] [Related]
12. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment.
Grigsby PW; Reddy RM; Moley JF; Hall BL
Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155
[TBL] [Abstract][Full Text] [Related]
13. Presence and Number of Lymph Node Metastases Are Associated With Compromised Survival for Patients Younger Than Age 45 Years With Papillary Thyroid Cancer.
Adam MA; Pura J; Goffredo P; Dinan MA; Reed SD; Scheri RP; Hyslop T; Roman SA; Sosa JA
J Clin Oncol; 2015 Jul; 33(21):2370-5. PubMed ID: 26077238
[TBL] [Abstract][Full Text] [Related]
14. Surgery for papillary thyroid carcinoma: is lobectomy enough?
Mendelsohn AH; Elashoff DA; Abemayor E; St John MA
Arch Otolaryngol Head Neck Surg; 2010 Nov; 136(11):1055-61. PubMed ID: 21079156
[TBL] [Abstract][Full Text] [Related]
15. Extent of surgery affects survival for papillary thyroid cancer.
Bilimoria KY; Bentrem DJ; Ko CY; Stewart AK; Winchester DP; Talamonti MS; Sturgeon C
Ann Surg; 2007 Sep; 246(3):375-81; discussion 381-4. PubMed ID: 17717441
[TBL] [Abstract][Full Text] [Related]
16. Impact of Timeliness of Resection and Thyroidectomy Margin Status on Survival for Patients with Anaplastic Thyroid Cancer: An Analysis of 335 Cases.
Goffredo P; Thomas SM; Adam MA; Sosa JA; Roman SA
Ann Surg Oncol; 2015 Dec; 22(13):4166-74. PubMed ID: 26271394
[TBL] [Abstract][Full Text] [Related]
17. Exploring the Relationship Between Patient Age and Cancer-Specific Survival in Papillary Thyroid Cancer: Rethinking Current Staging Systems.
Adam MA; Thomas S; Hyslop T; Scheri RP; Roman SA; Sosa JA
J Clin Oncol; 2016 Dec; 34(36):4415-4420. PubMed ID: 27998233
[TBL] [Abstract][Full Text] [Related]
18. Utilization of total thyroidectomy for papillary thyroid cancer in the United States.
Bilimoria KY; Bentrem DJ; Linn JG; Freel A; Yeh JJ; Stewart AK; Winchester DP; Ko CY; Talamonti MS; Sturgeon C
Surgery; 2007 Dec; 142(6):906-13; discussion 913.e1-2. PubMed ID: 18063075
[TBL] [Abstract][Full Text] [Related]
19. Does microscopic positive tumor margin in papillary thyroid cancer really matter?
Back K; Kim SK; Chai YJ; Kim JH; Choe JH; Kim JS
Surgery; 2019 Dec; 166(6):1160-1167. PubMed ID: 31582308
[TBL] [Abstract][Full Text] [Related]
20. T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?
Anderson KL; Youngwirth LM; Scheri RP; Stang MT; Roman SA; Sosa JA
Thyroid; 2016 Aug; 26(8):1046-52. PubMed ID: 27266722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
